Feasibility of routine hepatitis C screening for hospitalized patients
Pilot Study of the Feasibility of Routine Inpatient Hepatitis C Screening
This study is testing whether routine hepatitis C screening for all hospitalized patients can be successfully done in hospitals to help find and treat more cases of the virus.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 2500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 4 sites (Créteil and 3 other locations) |
| Trial ID | NCT04405024 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the feasibility and effectiveness of implementing systematic hepatitis C (HCV) screening in hospitalized patients across multiple medical and surgical departments in four hospitals in France. The initiative is part of a public health program targeting the eradication of HCV by 2025, focusing on universal screening regardless of known risk factors. The study will assess the number of patients screened, referred for consultation, and those who accept the consultation, thereby establishing a dedicated care pathway for HCV management.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized patients aged 18 and older who do not oppose participation.
Not a fit: Patients under 18 years of age, outpatients, or those in long-stay, maternity, or intensive care units may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier detection and treatment of hepatitis C, ultimately contributing to its eradication.
How similar studies have performed: Previous initiatives in France have shown promise in implementing hepatitis-free hospital projects, indicating potential success for this universal screening approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient over 18 years of age * Hospitalized during the study period * Non-opposition for participation in the Protocol Exclusion Criteria: * Patients under 18 years of age * Outpatient, long-stay, maternity and intensive care inpatients * Patients refusing blood collection * Patient may not understand the information sheet * Patient under guardianship
Where this trial is running
Créteil and 3 other locations
- CHI Créteil — Créteil, France (Recruiting)
- Grand Hôpital de l'Est Francilien - Site de Marne-la-Vallée — Jossigny, France (Recruiting)
- CH Meaux — Meaux, France (Recruiting)
- Chiv — Villeneuve-Saint-Georges, France (Recruiting)
Study contacts
- Study coordinator: Isabelle Rosa, PhD
- Email: isabelle.rosa@chicreteil.fr
- Phone: 01 45 17 50 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.